Protective effects of erythropoietin on myocardial infarction in rats: The role of AMP-activated protein kinase signaling pathway

American Journal of the Medical Sciences

Volumn 342, Issue 2, 2011, Pages 153-159

  Li, Xiu Jiang ^a   Wang, Xiao Wen ^a   Du, Yu Jun ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

AMPK; EPO; Myocardial infarction; NF B; Rat

Indexed keywords

ERYTHROPOIETIN RECEPTOR; HEART ENZYME; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ASSAY; ENZYME BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; UPREGULATION;

EID: 79961029900     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318210041d     Document Type: Article

References (39)

1. White HD, Chew DP. Acute myocardial infarction. Lancet 2008;372: 570-84.
2. Koury ST, Bondurant MC, Koury MJ. Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 1988;71:524-7. (Pubitemid 18089550)
3. Maxwell PH, Osmond MK, Pugh CW, et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993;44:1149-62. (Pubitemid 23316488)
4. Browne JK, Cohen AM, Egrie JC, et al. Erythropoietin: gene cloning, protein structure, and biological properties. Cold Spring Harb Symp Quant Biol 1986;51(Pt 1):693-702. (Pubitemid 17076759)
5. Jelkmann W, Wagner K. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann Hematol 2004;83:673-86. (Pubitemid 39440211)
6. Patel NS, Sharples EJ, Cuzzocrea S, et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004;66:983-9. (Pubitemid 39121002)
7. Grimm C, Wenzel A, Groszer M, et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002;8:718-24. (Pubitemid 34778725)
8. Kang YJ, Digicaylioglu M, Russo R, et al. Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders. Ann Neurol 2010;68:342-52.
9. Calapai G, Marciano MC, Corica F, et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 2000;401:349-56. (Pubitemid 30608719)
10. Neubauer AP, Voss W, Wachtendorf M, et al. Erythropoietin im-proves neurodevelopmental outcome of extremely preterm infants. Ann Neurol 2010;67:657-66.
11. Squadrito F, Altavilla D, Squadrito G, et al. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol 1999;127:482-8. (Pubitemid 29245687)
12. Sepodes B, Maio R, Pinto R, et al. Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat. Transpl Int 2006;19:919-26. (Pubitemid 44511117)
13. Lipsic E, van der Meer P, Henning RH, et al. Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion. J Cardiovasc Pharmacol 2004;44:473-9. (Pubitemid 39305089)
14. Cai Z, Manalo DJ, Wei G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemiareperfusion injury. Circulation 2003;108:79-85. (Pubitemid 36859024)
15. Cai Z, Semenza GL. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 2004;109:2050-3. (Pubitemid 38620210)
16. Calvillo L, Latini R, Kajstura J, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003;100: 4802-6. (Pubitemid 36457809)
17. Bullard AJ, Govewalla P, Yellon DM. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol 2005;100:397-403. (Pubitemid 41300494)
18. Abdelrahman M, Sharples EJ, McDonald MC, et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004;22:63-9. (Pubitemid 40228212)
19. Lipsic E, Schoemaker RG, van der Meer P, et al. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J Am Coll Cardiol 2006;48:2161-7. (Pubitemid 44855436)
20. Kahn BB, Alquier T, Carling D, et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005;1:15-25. (Pubitemid 43960587)
21. Zacharowski K, Otto M, Hafner G, et al. Reduction of myocardial infarct size with sCR1sLex, an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x. Br J Pharmacol 1999;128:945.
22. Fan Y, Shen F, Frenzel T, et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 2010; 67:488-97.
23. Hamdan FF, Piton A, Gauthier J, et al. De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy. Ann Neurol 2009; 65:748-53.
24. Gandy S, Simon AJ, Steele JW, et al. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers. Ann Neurol 2010;68:220-30.
25. Berrih-Aknin S, Ruhlmann N, Bismuth J, et al. CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. Ann Neurol 2009;66:521-31.
26. Li DJ, Tang Q, Shen FM, et al. Overexpressed alpha7 nicotinic acetylcholine receptor inhibited proinflammatory cytokine release in NIH3T3 cells. J Biosci Bioeng 2009;108:85-91.
27. Fombonne J, Rabizadeh S, Banwait S, et al. Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction. Ann Neurol 2009;65:294-303.
28. Parsa CJ, Kim J, Riel RU, et al. Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J Biol Chem 2004;279:20655-62. (Pubitemid 38656460)
29. Koury MJ, Bondurant MC. Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells. J Cell Physiol 1988;137:65-74.
30. Kobayashi H, Minatoguchi S, Yasuda S, et al. Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair. Cardiovasc Res 2008;79:611-20.
31. D'Andrea AD, Lodish HF, Wong GG. Expression cloning of the murine erythropoietin receptor. Cell 1989;57:277-85. (Pubitemid 19112366)
32. Yu X, Shacka JJ, Eells JB, et al. Erythropoietin receptor signalling is required for normal brain development. Development 2002;129: 505-16. (Pubitemid 34863815)
33. Liu ZY, Chin K, Noguchi CT. Tissue specific expression of human erythropoietin receptor in transgenic mice. Dev Biol 1994;166:159-69. (Pubitemid 24374755)
34. Wright GL, Hanlon P, Amin K, et al. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J 2004;18:1031-3. (Pubitemid 39561515)
35. Dyck JR, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 2006;574:95-112. (Pubitemid 43905800)
36. Hue L, Beauloye C, Marsin AS, et al. Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. J Mol Cell Cardiol 2002;34:1091-7. (Pubitemid 35205153)
37. Young LH, Li J, Baron SJ, et al. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 2005;15: 110-8. (Pubitemid 41021735)
38. Arad M, Seidman CE, Seidman JG. AMP-activated protein kinase in the heart: role during health and disease. Circ Res 2007;100:474-88. (Pubitemid 46673257)
39. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci 2004;29:18-24. (Pubitemid 38068476)